MIRA Pharmaceuticals, Inc. Common Stock Cash Flow-to-Debt Ratio
MIRA Pharmaceuticals, Inc. Common Stock cash flow-to-debt ratio. MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a Cash Flow-to-Debt Ratio of -29.53x as of June 2026, meaning its operating cash flow of $-1.21 Million could theoretically repay -30% of its total liabilities ($40.82K) in one year. Check MIRA Pharmaceuticals, Inc. Common Stock earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MIRA Pharmaceuticals, Inc. Common Stock (2020–2025)
Cash flow-to-debt ratio of MIRA Pharmaceuticals, Inc. Common Stock from 2020 to 2025. Historical debt coverage capacity for MIRA Pharmaceuticals, Inc. Common Stock across 6 annual periods. Also explore MIRA Pharmaceuticals, Inc. Common Stock net asset momentum to track the company's year-over-year net asset growth rate.
MIRA Pharmaceuticals, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2020–2025)
MIRA Pharmaceuticals, Inc. Common Stock cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for MIRA Pharmaceuticals, Inc. Common Stock. For the full cash flow conversion analysis, see MIRA Pharmaceuticals, Inc. Common Stock (MIRA) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.64x | $-4.66 Million | $702.07K | ▲ +13.6% |
| 2024 | -7.69x | $-5.56 Million | $723.35K | ▲ +5.3% |
| 2023 | -8.12x | $-4.53 Million | $558.10K | ▼ -110.7% |
| 2022 | -3.85x | $-5.60 Million | $1.45 Million | ▼ -206.3% |
| 2021 | -1.26x | $-1.38 Million | $1.09 Million | ▼ -67.2% |
| 2020 | -0.75x | $-67.99K | $90.36K | — |